Literature DB >> 10623838

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells.

E Loing1, M Andrieu, K Thiam, D Schörner, K H Wiesmüller, A Hosmalin, G Jung, H Gras-Masse.   

Abstract

The delineation of the minimal requirements for efficient delivery of functional cytotoxic epitopes into APC could be a step toward the definition of "minimal length" lipopeptides for the modulation of CTL activity. Several analogues of the HLA-A*0201-restricted HIV-1 polymerase (pol476-484) minimal cytotoxic epitope were obtained by modifying P0, P1, or P10 positions by a single N epsilon-palmitoyl-lysine residue. The use of fluorescent derivatives confirmed the cell-permeating activities and suggested that a P0- and a P1-modified lipopeptide possessing ionizable extremities fulfills the structural requirements for MHC loading. The expressions of HLA-peptide complexes at the surface of TAP-deficient cells incubated with the parent epitope or lipopeptide derivatives were compared, in terms of intensity and stability. Both lipopeptides induced a considerably prolonged expression of conformationally correct complexes, which were dependent on the integrity of the exocytosis pathway, suggesting a dynamic mechanism of formation or reloading of the complexes from an intracellular pool. The agonistic activities of the different HLA-peptide complexes were evaluated using two independent T cell lines from HIV-infected donors. We report that a lipodecapeptide obtained by N-terminal addition of a N epsilon-palmitoyl-lysine to the pol476-484 epitope was able to increase the life span of functional presentation to cytotoxic T cells specific for the parent peptide.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623838     DOI: 10.4049/jimmunol.164.2.900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.

Authors:  B Langhans; I Braunschweiger; S Schweitzer; G Jung; G Inchauspé; T Sauerbruch; U Spengler
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.

Authors:  Xiuli Zhang; Annie Issagholian; Eric A Berg; Jordan B Fishman; Anthony B Nesburn; Lbachir BenMohamed
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus.

Authors:  Georgia Deliyannis; David C Jackson; Nicholas J Ede; Weiguang Zeng; Irene Hourdakis; Evaline Sakabetis; Lorena E Brown
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses.

Authors:  Lbachir BenMohamed; Radhika Krishnan; Catherine Auge; James F Primus; Don J Diamond
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

Review 5.  TLR-based immune adjuvants.

Authors:  Folkert Steinhagen; Takeshi Kinjo; Christian Bode; Dennis M Klinman
Journal:  Vaccine       Date:  2010-08-14       Impact factor: 3.641

6.  Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

Authors:  Muriel Andrieu; Jean-François Desoutter; Estelle Loing; Jésintha Gaston; Daniel Hanau; Jean-Gérard Guillet; Anne Hosmalin
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.

Authors:  Yoshio Fujita; Hiroaki Taguchi
Journal:  Chem Cent J       Date:  2011-08-23       Impact factor: 4.215

8.  Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.

Authors:  Rakhee Sachdeva; Akhil C Banerjea; Nancy Malla; Mohan Lal Dubey
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

Review 9.  Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.

Authors:  Mehfuz Zaman; Istvan Toth
Journal:  Front Immunol       Date:  2013-10-09       Impact factor: 7.561

Review 10.  The Interplay between Daptomycin and the Immune System.

Authors:  Theodoros Kelesidis
Journal:  Front Immunol       Date:  2014-02-12       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.